Submission Details
| 510(k) Number | K781653 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 1978 |
| Decision Date | November 08, 1978 |
| Days to Decision | 42 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
K781653 is an FDA 510(k) clearance for the NEPHELRATE ANTISERUMS C3C, a Complement C3, Antigen, Antiserum, Control (Class II — Special Controls, product code CZW), submitted by Antibodies, Inc. (Mchenry, US). The FDA issued a Cleared decision on November 8, 1978, 42 days after receiving the submission on September 27, 1978. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5240.
| 510(k) Number | K781653 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 27, 1978 |
| Decision Date | November 08, 1978 |
| Days to Decision | 42 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
| Product Code | CZW — Complement C3, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5240 |